ProCE Banner Activity

Clearing the Path: HCV Screening and Treatment During Pregnancy

Clinical Thought

Read my commentary on the various pathways healthcare professionals can use to optimize hepatitis C virus (HCV) screening and treatment in pregnant individuals, including strategies to improve screening, considerations for HCV treatment before and during pregnancy, use of a multidisciplinary approach to care, and the importance of postpartum linkage to HCV care. 

Released: October 31, 2024

Expiration: October 30, 2025

Share

Faculty

Tatyana Kushner

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Gastroenterology/ Hepatology
Department of Obstetrics & Gynecology
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC, in partnership with the Asian Health Foundation, Hepatitis B Foundation, and HealthHCV

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Health HCV

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Disclosure

Primary Author

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Gastroenterology/ Hepatology
Department of Obstetrics & Gynecology
Weill Cornell Medicine
New York, New York

Tatyana Kushner, MD, MSCE: consultant/advisor/speaker: AbbVie, Aligos, GlaxoSmithKline; researcher: Gilead.